E213 - Metabolic dysfunction–associated fatty liver disease an update
About this episode
Laura Beaton interviews Richard O'Halloran about metabolic dysfunction–associated fatty liver disease, discussing risk factors, diagnostic tests, and management strategies.
Laura Beaton talks to hepatology research fellow Richard O'Halloran about his paper on metabolic dysfunction–associated fatty liver disease (MAFLD). Richard outlines risk factors and comorbidities to consider, and diagnostic tests for MAFLD. The conversation also covers management of MAFLD through risk stratification, addressing health risk behaviours, and surveillance. Read the full article in Australian Prescriber .
More episodes of Australian Prescriber Podcast
- E212 - Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals
- E211 - Preventing infections in immunosuppressed patients
- E210 - Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis – is it effective?
- E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline
- E208 - Pharmacological management of attention deficit hyperactivity disorder in adults
- E207 - Injectable drugs for weight management
Explore listener stats, chart rankings, contacts and more on the Australian Prescriber Podcast podcast page.